Issue 5/2011

Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells (361 — 370)

L. KUCEROVA, M. KOVACOVICOVA, S. POLAK, M. BOHAC, J. FEDELES, D. PALENCAR, M. MATUSKOVA

DOI: 10.4149/neo_2011_05_361

Expression of the nonclassical HLA class I and MICA/B molecules in human hepatocellular carcinoma (371 — 376)

A. CHEN, Y. SHEN, M. XIA, L. XU, N. PAN, Y. YIN, F.  MIAO, C. SHEN, W. XIE, J. ZHANG

DOI: 10.4149/neo_2011_05_371

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients (377 — 385)

J. HALAMKOVA, I. KISS, Z. PAVLOVSKY, J. TOMASEK, J. JARKOVSKY, Z. CECH, S. TUCEK, L. HANAKOVA, M. MOULIS, J. ZAVRELOVA, M. MAN, P. BENDA, O. ROBEK, Z. KALA, M. PENKA

DOI: 10.4149/neo_2011_05_377

Biological activity of plant extract isolated from Papaver rhoeas on human lymfoblastoid cell line (386 — 391)

K. HASPLOVA, A. HUDECOVA, E. MIADOKOVA, Z. MAGDOLENOVA, E. GALOVA, L. VACULCIKOVA, F. GREGAN, M. DUSINSKA

DOI: 10.4149/neo_2011_05_386

Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma (392 — 395)

O. HAVRANEK, M. SPACEK, P. HUBACEK, H. MOCIKOVA, J. MARKOVA, M. TRNENY, Z. KLEIBL

DOI: 10.4149/neo_2011_05_392

The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro (396 — 405)

C. HUANG, G. YANG, T. JIANG, G. ZHU, H. LI, Z. QIU

DOI: 10.4149/neo_2011_05_396

Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin (406 — 414)

M. KREJCI, Y. BRYCHTOVA, M. DOUBEK, M. TOMISKA, M. NAVRATIL, Z. RACIL, D. DVORAKOVA, O. HORKY, M. LENGEROVA, S. POSPISILOVA, J. MAYER

DOI: 10.4149/neo_2011_05_406

Rhabdomyosarcoma: Molecular analysis of Igf2, MyoD1 and Myogenin expression. (415 — 423)

L. KRSKOVA, A. AUGUSTINAKOVA, E. DRAHOKOUPILOVA, D. SUMERAUER, P. MUDRY, R. KODET

DOI: 10.4149/neo_2011_05_415

Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats (424 — 429)

L. LACKOVICOVA, L. BANOVSKA, J. BUNDZIKOVA, P. JANEGA, J. BIZIK, A. KISS, B. MRAVEC

DOI: 10.4149/neo_2011_05_424

Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients (430 — 435)

P. PLUTA, B. CEBULA-OBRZUT, V. EHEMANN, A. PLUTA, A. WIERZBOWSKA, J. PIEKARSKI, A. BILSKI, D. NEJC, R. KORDEK, T. ROBAK, P. SMOLEWSKI, A. JEZIORSKI

DOI: 10.4149/neo_2011_05_430

Cloning expression, monoclonal antibody preparation and serologic study of mammaglobin in breast cancer (436 — 440)

Y. HUANG, H. Q. ZHANG, Q. WANG, X. G. SONG, G. H. WANG, Q. GUAN, W. ZHO, F. HUO, C. Z. YU, Y. J. ZENG

DOI: 10.4149/neo_2011_05_436

Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis (441 — 448)

J. D. TONG, N. L. JIAO, Y. X. WANG, Y. W. ZHANG, F. HAN

DOI: 10.4149/neo_2011_05_441

Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance (449 — 454)

H. Z. ZENG, Y. Q. QU, A. B. LIANG, A. M. DENG, W. J. ZHANG, B. XIU, H. WANG, H. WANG

DOI: 10.4149/neo_2011_05_449